emergent logo.jpg
Emergent BioSolutions Reports First Quarter 2018 Financial Results
May 03, 2018 16:30 ET | Emergent BioSolutions
Reaffirms full year 2018 financial forecast and operational goalsProvides Q2 2018 revenue forecast of $205M-$230M GAITHERSBURG, Md., May 03, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions...
emergent logo.jpg
Emergent BioSolutions Announces Successful Completion of Mutual Recognition Procedure for Market Authorization of BioThrax in European Countries
April 12, 2018 06:30 ET | Emergent Biosolutions, Inc.
GAITHERSBURG, Md., April 12, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the successful completion of the Mutual Recognition Procedure (MRP) for market...
emerge.png
Emergent BioSolutions Reports Third Quarter and Nine Months 2017 Financial Results; Raises Calendar Year 2017 Guidance
November 02, 2017 16:15 ET | Emergent Biosolutions, Inc.
GAITHERSBURG, Md., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and nine months ended September 30, 2017. FINANCIAL HIGHLIGHTS ...
emerge.png
Emergent BioSolutions to Release Third Quarter and Nine Months 2017 Financial Results and Conduct a Conference Call on November 2, 2017
October 19, 2017 07:00 ET | Emergent Biosolutions, Inc.
GAITHERSBURG, Md., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS) will release its financial results for the third quarter and nine months of 2017 immediately after market close...
emerge.png
Emergent BioSolutions Announces Closing of New $200 Million Senior Secured Credit Facility
October 02, 2017 07:00 ET | Emergent BioSolutions Inc.
GAITHERSBURG, Md., Oct. 02, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has completed a new five-year, $200 million syndicated senior secured credit...
emerge.png
Emergent BioSolutions Reports Second Quarter and Six Months 2017 Financial Results; Reaffirms Calendar Year 2017 Guidance
August 03, 2017 16:15 ET | Emergent BioSolutions Inc.
GAITHERSBURG, Md., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and six months ended June 30, 2017. FINANCIAL HIGHLIGHTS (in...
emerge.png
Emergent BioSolutions to Release Second Quarter 2017 Financial Results and Conduct a Conference Call on August 3, 2017
July 20, 2017 07:00 ET | Emergent BioSolutions Inc.
GAITHERSBURG, Md., July 20, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will release its second quarter financial results immediately after market close on Thursday, August 3,...
emerge.png
Emergent BioSolutions to Hold Annual Meeting of Stockholders Thursday May 25, 2017 at 9:00 AM EDT; Webcast Will be Available
May 11, 2017 07:00 ET | Emergent BioSolutions Inc.
GAITHERSBURG, Md., May 11, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) has announced that it will hold its Annual Meeting of Stockholders on Thursday, May 25, 2017 beginning at...
emerge.png
Emergent BioSolutions Reports First Quarter 2017 Financial Results; Reaffirms 2017 Guidance
May 04, 2017 16:15 ET | Emergent BioSolutions Inc.
GAITHERSBURG, Md., May 04, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and three months ended March 31, 2017. FINANCIAL HIGHLIGHTS ...
emerge.png
Emergent BioSolutions to Release First Quarter 2017 Financial Results and Conduct a Conference Call on May 4, 2017
April 20, 2017 07:00 ET | Emergent BioSolutions Inc.
GAITHERSBURG, Md., April 20, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, May 4, 2017 at 5:00 pm (Eastern Time) to discuss the financial...